ContraFect to Present at Biotech Showcase 2017 Conference
January 04, 2017 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - January 04, 2017) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at 28th Annual Piper Jaffray Healthcare Conference
November 23, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - November 23, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Awarded $2.1 Million PRMRP Grant to Support Development of CF-301
November 17, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - November 17, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Announces First Quarter 2016 Results
May 10, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - May 10, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation to Announce First Quarter 2016 Results on May 10, 2016
May 03, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - May 03, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a clinical-stage biotechnology company focused on the discovery and...
ContraFect to Present CF-301 Phase 1 Trial Data at the 26th ECCMID Conference
March 29, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 29, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a biotechnology company focused on the discovery and...
ContraFect Corporation Announces Organizational Changes
March 22, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 22, 2016) - ContraFect Corporation (NASDAQ: CFRX)(NASDAQ: CFRXW) (the "Company"), a biotechnology company focused on the discovery and development of protein...
ContraFect Announces Fourth Quarter and Full Year 2015 Results
March 15, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 15, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Corporation to Announce Fourth Quarter and Full Year 2015 Results on March 15, 2016
March 08, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 08, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a clinical-stage biotechnology company focused on the discovery and...